Aurobindo Pharma - Quaterly Results

10 Feb 2024 Evaluate
The company witnessed a 14.03% growth in the revenue at Rs. 26920.30 millions for the quarter ended December 2023 as compared to Rs. 23609.10 millions during the year-ago period.Profit after tax for the quarter ended December 2023 reported a huge growth of 93.16% to Rs. 6237.80  millions from Rs. 3229.40 millions.The company reported a good operating profit of 8128.20 millions compared to 5222.40 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 26920.30 23609.10 14.03 77516.10 60507.70 28.11 127922.80 112871.40 13.33
Other Income 3311.30 780.10 324.47 4930.90 1713.20 187.82 4337.60 6709.90 -35.36
PBIDT 8128.20 5222.40 55.64 19423.40 10960.40 77.21 21646.80 21443.90 0.95
Interest 612.50 252.60 142.48 1295.30 428.00 202.64 1149.80 169.40 578.75
PBDT 7515.70 4969.80 51.23 18128.10 10532.40 72.12 20497.00 20527.40 -0.15
Depreciation 643.50 598.70 7.48 1897.70 1765.80 7.47 4353.50 4152.60 4.84
PBT 6872.20 4371.10 57.22 16230.40 8766.60 85.14 16143.50 16374.80 -1.41
TAX 634.40 1141.70 -44.43 3016.10 2336.40 29.09 3839.40 1827.70 110.07
Deferred Tax -735.10 -91.90 699.89 -888.10 -225.70 293.49 -230.80 -1969.30 -88.28
PAT 6237.80 3229.40 93.16 13214.30 6430.20 105.50 12304.10 14547.10 -15.42
Equity 585.90 585.90 0.00 585.90 585.90 0.00 585.90 585.90 0.00
PBIDTM(%) 30.19 22.12 36.50 25.06 18.11 38.33 16.92 19.00 -10.93

Aurobindo Pharma Share Price

1223.10 2.90 (0.24%)
22-Nov-2024 12:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.05
Dr. Reddys Lab 1207.90
Cipla 1485.60
Lupin 2058.70
Zydus Lifesciences 946.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.